Analysis of the Risk of COVID-19 in the Post-Vaccination Period Based on the Results of a Multicenter Study — a Survey of Medical Workers

Author:

Medvedeva Evgeniya A.ORCID,Zykov Kirill A.ORCID,Marin Herman G.ORCID,Ploskireva Antonina A.ORCID,Svitich Oksana A.ORCID,Kaira Alla N.ORCID,Nazarov Dmitry A.ORCID,Volynkov Igor O.ORCID,Kuzin Alexander A.ORCID,Kubyshkin Anatoliy V.ORCID,Tutelyan Alexey V.ORCID,Beregovykh Valery V.ORCID,Chebotareva Tatyana A.ORCID

Abstract

Background. One of the vulnerable categories of the population during the COVID-19 pandemic has become employees of medical and educational institutions. Timely and properly organized prevention, based on anti-epidemic measures based on vaccination, is necessary not only to reduce the incidence of the disease, but primarily to reduce the severity in case of its occurrence, reduce the risk of hospitalization. Understanding the effectiveness of preventing SARS-CoV-2 infections among healthcare workers is a critical component of occupational health and safety policy and strategy. Aim — analysis of the incidence of COVID-19 after vaccination among medical staff and teaching staff of medical higher educational institutions. Methods. In the period from January to March 2022, a cross-sectional retrospective single-stage online study was conducted (anonymous questionnaires posted on the Anketologist platform). The survey was completed by 6032 respondents (82% efficiency). According to the criteria, 2114 respondents were excluded from the study. The analysis was carried out according to the questionnaires of 3918 respondents, including an assessment of the incidence after vaccination (n = 3668 respondents). Results. Fell ill after a double vaccination for 5 months — 663 (16.9%). Unvaccinated respondents reported that within 5 months. prior to the survey, 116 (46.4%) had a laboratory-confirmed new coronavirus infection. Lack of vaccination increased the risk of SARS-CoV-2 (OR 1.78 ± 0.14; 95% CI: 1.34–2.36). Efficiency within 5 months post-vaccination period was 55.5% (95% CI: 42.2–57.7%) for Sputnik V; 71.9% (95% CI: 68.1–85.4%) — Sputnik Light. It was found that gender and age were not a risk factor for the onset of the disease in the post-vaccination period. The presence of a history of previous COVID-19 increased the risk of disease in the post-vaccination period in individuals under 35 years of age (OR 2.323 ± 0.102; 95% CI: 1.903–2.836), aged 36–64 years (OR 2.547 ± 0.086; 95% CI: 2.150–3.016), older than 65 years (OR 1.323 ± 0.280; 95% CI: 0.764–2.290). Respondents with a history of a combination of chronic cardiovascular pathology and past COVID-19 had a higher risk of getting sick in the post-vaccination period (OR 1.338 ± 0.160; 95% CI: 0.977–1.832). Conclusion. According to the questionnaire, an important factor affecting the risk of COVID-19 in the post-vaccination period is the presence of SARS-CoV-2 before vaccination, which can increase the chance of developing the disease in the presence of other risk factors (chronic pathology, age, smoking, alcohol consumption).

Publisher

Paediatrician Publishers LLC

Reference29 articles.

1. Новая коронавирусная инфекция COVID-19: профессиональные аспекты сохранения здоровья и безопасности медицинских работников: методические рекомендации / под ред. И.В. Бухтиярова, Ю.Ю. Горблянского. — М.: АМТ, ФГБНУ «НИИ МТ», 2021. — 132 c. [New coronavirus infection COVID-19: professional aspects of maintaining the health and safety of medical workers: guidelines. Bukhtiyarova IV, Gorblyansky YuYu. (eds). Moscow: AMT, FGBNU “NII MT”, Media Sfera; 2021. (In Russ).]

2. Weekly Epidemiological Update on COVID-19 — 20 April 2023. 139 ed. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---20-april-2023

3. WHO target product profiles for COVID-19 vaccines. 2022 Jun. Available from: https://www.who.int/publications/m/item/who-target-product-profiles-for-covid-19-vaccines

4. Костинов М.П., Полищук В.Б., Свитич О.А., и др. Вакцинопрофилактика COVID-19 у пациентов с коморбидными заболеваниями: руководство для врачей / под ред. М.П. Костинова. — М.: Группа МДВ, 2022. — 175 с. [Kostinov MP, Polishchuk VB, Svitich OA, et al. Vaccine prevention of COVID-19 in patients with comorbid diseases: a guide for physicians. Kostinov MP. (ed.). Moscow: MDV Group; 2022. (In Russ.)]

5. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3